Tumor-bowel fistula: What radiologists should know

Abdominal Imaging

Volumn 38, Issue 5, 2013, Pages 1014-1023

  Tirumani, Sree Harsha ^a,b   Baez, Juan C ^b   Jagannathan, Jyothi P ^a,b   Shinagare, Atul B ^b   Ramaiya, Nikhil H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CT; Fistula; Molecular targeted therapies; Tumor bowel fistula

Indexed keywords

BEVACIZUMAB;

CANCER RADIOTHERAPY; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTESTINE FISTULA; INTESTINE PERFORATION; METASTASIS; MOLECULARLY TARGETED THERAPY; PATHOGENESIS; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; RADIOLOGIST; RECTUM CANCER; REVIEW; TUMOR BOWEL FISTULA;

ANGIOGENESIS INHIBITORS; HUMANS; INTESTINAL FISTULA; INTESTINAL NEOPLASMS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84884704838     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-013-9987-6     Document Type: Review

References (24)

1. Pickhardt PJ, Bhalla S, Balfe DM (2002) Acquired gastrointestinal fistulas: classification, etiologies, and imaging evaluation. Radiology 224:9-23
2. Falconi M, Pederzoli P (2001) The relevance of gastrointestinal fistulae in clinical practice: a review. Gut 49:iv2-iv10
3. Narayanan P, Nobbenhuis M, Reynolds KM, Sahdev A, et al. (2009) Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics 29:1073-1083
4. Bats AS, Rockall AG, Singh N, Reznek RH, Jeyarajah A (2010) Perforation of a malignant ovarian tumor into the recto-sigmoid colon. Acta Obstet Gynecol Scand 89:1362-1363
5. Kim SJ, Kimoto Y, Nakamura H, et al. (1999) Ovarian carcinoma with fistula formation to the sigmoid colon and ileum: report of a case. Surg Today 29:449-452
6. Yahagi N, Kobayashi Y, Ohara T, et al. (2011) Ovarian carcinoma complicated by sigmoid colon fistula formation: a case report and review of the literature. J Obstet Gynaecol Res 37:250-253
7. Mahajan SK, Sood BR, Vaidya P, Thakur S, Pal LS (2006) Malignant colo-jejunal fistula - a rare internal fistula. J Assoc Physicians India 54:336-337
8. Majeed TA, Gaurav A, Shilpa D, et al. (2011) Malignant coloduodenal fistulas - review of literature and case report. Indian J Surg Oncol 2:205-209
9. Chun HB, Baek IH, Lee MS, et al. (2011) Jejunocolic fistula associated with an intestinal T cell lymphoma. Gut Liver 5:387-390
10. Emmert C, Kohler U (1996) Management of genital fistulas in patients with cervical cancer. Arch Gynecol Obstet 259:19-24
11. Biewenga P, Mutsaerts MA, Stalpers LJ, et al. (2010) Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer 20:471-475
12. Shinagare AB, Howard SA, Krajewski KM, et al. (2012) Pneumatosis intestinalis and bowel perforation associated with molecular targeted therapy: an emerging problem and the role of radiologists in its management. AJR Am J Roentgenol 199:1259-1265
13. Abu-Hejleh T, Mezhir JJ, Goodheart MJ, Halfdanarson TR (2012) Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancers. Curr Oncol Rep 14:277-284
14. Badgwell B, Camp E, Feig B, et al. (2008) Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 19:577-582
15. Sliesoraitis S, Tawfik B (2011) Bevacizumab-induced bowel perforation. J Am Osteopath Assoc 111:437-441
16. Tol J, Cats A, Mol L, et al. (2008) Gastrointestinal ulceration as a possible side effect of bevacizumab which may herald perforation. Invest New Drugs 26:393-397
17. Faivre S, Delbaldo C, Vera K, et al. (2006) Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncol 24:25-35
18. Curley SA, Marra P, Beaty K, et al. (2004) Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239:450-458
19. Ong GY, Changchien CS, Lee CM, et al. (2004) Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures. Eur J Gastroenterol Hepatol 16:737-742
20. Wang CY, Leung SW, Wang JH, Yu PC, Wang CC (2009) Delayed spontaneous hepatogastric fistula formation following transcatheter arterial embolisation and radiotherapy for hepatocellular carcinoma. Br J Radiol 82:e105-e107
21. Asmis TR, Chung KY, Teitcher JB, Kelsen DP, Shah MA (2008) Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity. Invest New Drugs 26:95-96
22. Chow H, Jung A, Talbott J, et al. (2011) Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequences. J Comput Assist Tomogr 35:86-90
23. Saif MW, Elfiky A, Salem RR (2007) Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol 14:1860-1869
24. Hurwitz H, Fehrenbacher L, Novotny W, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342